KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Equity Average (2016 - 2025)

Historic Equity Average for Dynavax Technologies (DVAX) over the last 15 years, with Q3 2025 value amounting to $514.2 million.

  • Dynavax Technologies' Equity Average fell 2235.0% to $514.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $514.2 million, marking a year-over-year decrease of 2235.0%. This contributed to the annual value of $609.4 million for FY2024, which is 131.21% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' Equity Average is $514.2 million, which was down 2235.0% from $512.6 million recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Equity Average peaked at $662.1 million during Q3 2024, and registered a low of $75.5 million during Q3 2021.
  • Moreover, its 5-year median value for Equity Average was $540.8 million (2022), whereas its average is $447.1 million.
  • As far as peak fluctuations go, Dynavax Technologies' Equity Average surged by 68778.46% in 2021, and later tumbled by 2235.0% in 2025.
  • Quarter analysis of 5 years shows Dynavax Technologies' Equity Average stood at $145.0 million in 2021, then skyrocketed by 273.03% to $540.8 million in 2022, then rose by 13.44% to $613.5 million in 2023, then grew by 4.18% to $639.1 million in 2024, then decreased by 19.55% to $514.2 million in 2025.
  • Its last three reported values are $514.2 million in Q3 2025, $512.6 million for Q2 2025, and $563.9 million during Q1 2025.